104
Participants
Start Date
March 15, 2021
Primary Completion Date
June 28, 2024
Study Completion Date
June 28, 2024
HC-1119
oral once daily 80 mg
Enzalutamide
oral once daily 160 mg
Kepler Universitätsklinikum Linz, Linz
Icon Cancer Care Gold Coast, Southport
Odense Universitetshospital, Odense C
Ashford Cancer Centre Research, Kurralta Park
Affinity Clinical Research, Nedlands
Aalborg Universitetshospital, Aalborg
C.H. Regional Reina Sofia - PPDS, Córdoba
Keystone Urology Specialists, Lancaster
MidLantic Urology, Bala-Cynwyd
Urologic Surgeons of Washington, Washington D.C.
Hospital Lucus Augusti, Lugo
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario de Malaga - Hospital Civil, Málaga
Tampereen yliopistollinen sairaala, Tampere
Azienda Ospedaliera Universitaria Integrata Di Verona, Verona
Hospital Universitario Virgen del Rocio - PPDS, Seville
UroGynZentrum Wall, Wuppertal
Clinical Research Solutions PC, Middleburg Heights
Fundacion Instituto Valenciano de Oncologia, Valencia
First Urology PSC, 101 Hospital Boulevard, Jeffersonville
Universitätsklinikum Bonn, Bonn
CHRU Lille, Lille
Seinäjoen Keskussairaala, Seinäjoki
Centre Léon Berard, Lyon
Centre Hospitalier Lyon Sud, Pierre-Bénite
Centre Jean Bernard Clinique Victor Hugo, Le Mans
Universitätsklinikum Tübingen, Tübingen
Urologische Studienpraxis, Nürtingen
Urology Center of Colorado, 2777 Mile High Stadium Circle, Denver
Oulun Yliopistollinen Sairaala, Oulu
Hopital Foch, Suresnes
Hopital d'Instruction des Armées de Begin, Saint-Mandé
Providence Regional Cancer System, Lacey
Ivanovo Regional Oncology Dispensary, Ivanovo
First St. Petersburg State Medical University n.a. I.P Pavlov, Saint Petersburg
GBUZ Saint Petersburg Clinical Research Center of Specialized Types of Care (Oncology), Saint Petersburg
Hospital Orkli LLC, Saint Petersburg
Federal State Institution Medical Radiology Research Center, Obninsk
Clinical Oncology Dispensary, Omsk
Altay Regional Oncology Center, Barnaul
Urology San Antonio Stone Oak, 18915 Meisner Drive, San Antonio
Fe/Male Health Centre, Oakville
CIUSSS de l'Estrie-CHUS, Sherbrooke
Helsinki University Hospital Comprehensive Cancer Center - PPDS, Helsinki
Azienda Ospedaliera S Maria Di Terni, Terni
Canisius Wilhelmina Ziekenhuis, Nijmegen
Catharina Hospital, Eindhoven
Antonius Ziekenhuis, Sneek
Hagaziekenhuis, The Hague
Clinical Research Center Spolka z Ograniczona, Poznan
NZOZ Centrum Urologiczne Sp zoo, Mysłowice
Onko-Centrum Sp. z o.o., Lublin
Urologica Praktyka Lekarska Adam Marcheluk, Siedlce
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw
Diana Princess of Wales Hospital, Grimsby
Belfast City Hospital, Belfast
Royal Marsden Hospital - London, London
Mount Vernon Hospital, Northwood
Lead Sponsor
Hinova Pharmaceuticals USA, Inc.
INDUSTRY